Alligator is a clinical-stage biotechnology company developing antibody-based pharmaceuticals for cancer treatment. Alligator specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies, with full focus on lead candidate mitazalimab.
Updated 2025-03-04